首页> 美国卫生研究院文献>Journal of Visualized Surgery >Endoscopic Port AccessTM left ventricle outflow tract resection and atrioventricular valve surgery
【2h】

Endoscopic Port AccessTM left ventricle outflow tract resection and atrioventricular valve surgery

机译:内窥镜检查左室流出道切除术和房室瓣膜手术

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The continuous evolution in robotic-, endoscopic- and trans-catheter cardiac interventions resulted in innovative techniques that simultaneously address left ventricular outflow tract obstruction (LVOTO) and concomitant atrioventricular valve (AVV) pathology in the context of hypertrophic obstructive cardiomyopathy (HOCM). We present our brief report of 13 consecutive HOCM patients with concomitant AVV disease, who underwent endoscopic left ventricular septal myomectomy (LVSM) and AVV surgery by Endoscopic Port AccessTM Surgery (EPAS) between March 1st 2010 and October 31st 2015. Our EPAS technique in the context of HOCM utilizes peripheral cardiopulmonary bypass, endo-aortic balloon occlusion and a 4-cm right antero-lateral thoracic working port. Access to the LVOTO is obtained by detaching the anterior mitral valve (MV) leaflet from the annulus. Controlled sharp LVSM is then performed from the aortic leaflet base to the papillary muscles. Subsequent routine AVV surgery is performed using long shafted instruments. There were no sternotomy conversions, LVSM complications or 30-day mortalities. The mean length of hospitalization was 17.7±18.1 days. Long-term clinical and echocardiographic analysis of 645.7 patient-months (n=13, 100.0% complete) identified two late mortalities, which were not procedure-, HOCM- or AVV-related. All patients (n=13, 100.0%), including the late mortalities, had significant improvement in their quality of life, a 100% long-term freedom from re-intervention and no residual peak instantaneous LVOTO gradients more than 15 mmHg. This brief report emphasises that simultaneous LVSM and concomitant AVV surgery by EPAS can safely be performed in experienced centres with favourable long-term outcomes.
机译:机器人,内镜和经导管心脏干预的不断发展产生了创新技术,这些技术可同时解决肥厚型梗阻性心肌病(HOCM)情况下的左心室流出道梗阻(LVOTO)和伴随的房室瓣膜(AVV)病理。我们提供了13例HOCM并发AVV疾病的简要报告,这些患者在2010年3月1日至10月之间接受了内窥镜Port Access TM 手术(EPAS)进行内镜左室间隔子宫肌瘤切除术(LVSM)和AVV手术2015年3月31日。在HOCM中,我们的EPAS技术利用了外围心肺旁路,主动脉内球囊闭塞和4 cm右前外侧胸廓工作端口。 LVOTO的进入是通过从瓣环上拆下前二尖瓣(MV)小叶获得的。然后从主动脉小叶基底到乳头肌进行受控的尖锐LVSM。随后的常规AVV手术是使用长柄器械进行的。没有胸骨切开术转换,LVSM并发症或30天死亡率。平均住院时间为17.7±18.1天。对645.7个患者月的长期临床和超声心动图分析(n = 13,完成率100.0%)确定了两个晚期死亡率,这与手术,HOCM或AVV不相关。所有患者(n = 13,100.0%)(包括晚期死亡)的生活质量都有显着改善,长期无需再次干预即可100%长期生活,并且没有超过15 mmHg的残留峰值瞬时LVOTO梯度。这份简短的报告强调,可以在经验丰富的中心安全地进行由EPAS同时进行的LVSM和伴随的AVV手术,并具有良好的长期效果。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号